| Evaluating warfarin management by pharmacists in a community teaching hospital. | Consult Pharm | 2014 Feb | 24513419 |
| A practical approach to minimize the interaction of dietary vitamin K withwarfarin. | J Clin Pharm Ther | 2014 Feb | 24383939 |
| Local verification and assignment of mean normal prothrombin time andInternational Sensitivity Index values across various instruments: recentexperience and outcome from North America. | Semin Thromb Hemost | 2014 Feb | 24381152 |
| Drug-drug interactions between sucroferric oxyhydroxide and losartan, furosemide,omeprazole, digoxin and warfarin in healthy subjects. | J Nephrol | 2014 Dec | 24699894 |
| Vitamin E-drug interactions: molecular basis and clinical relevance. | Nutr Res Rev | 2014 Dec | 25225959 |
| Medicinal plant activity on Helicobacter pylori related diseases. | World J Gastroenterol | 2014 Aug 14 | 25132753 |
| Hospital length of stay of nonvalvular atrial fibrillation patients who wereadministered Rivaroxaban versus Warfarin with and without pretreatment parenteralanticoagulants therapies. | Hosp Pract (1995) | 2014 Aug | 25255403 |
| Evaluation of halogenated coumarins for antimosquito properties. | ScientificWorldJournal | 2014 | 25610898 |
| Balancing the benefits and risks of 2 doses of dabigatran compared with warfarin in atrial fibrillation. | J Am Coll Cardiol | 2013 Sep 3 | 23770182 |
| Cost implications of formulary decisions on oral anticoagulants in nonvalvularatrial fibrillation. | J Manag Care Pharm | 2013 Nov-Dec | 24156648 |